JP2023543898A5 - - Google Patents
Info
- Publication number
- JP2023543898A5 JP2023543898A5 JP2023520059A JP2023520059A JP2023543898A5 JP 2023543898 A5 JP2023543898 A5 JP 2023543898A5 JP 2023520059 A JP2023520059 A JP 2023520059A JP 2023520059 A JP2023520059 A JP 2023520059A JP 2023543898 A5 JP2023543898 A5 JP 2023543898A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063087095P | 2020-10-02 | 2020-10-02 | |
| US63/087,095 | 2020-10-02 | ||
| PCT/US2021/052001 WO2022072244A1 (en) | 2020-10-02 | 2021-09-24 | Methods for reducing apociii expression |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023543898A JP2023543898A (ja) | 2023-10-18 |
| JP2023543898A5 true JP2023543898A5 (https=) | 2024-10-02 |
| JPWO2022072244A5 JPWO2022072244A5 (https=) | 2024-10-02 |
Family
ID=80950871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023520059A Pending JP2023543898A (ja) | 2020-10-02 | 2021-09-24 | Ａｐｏｃｉｉｉ発現を減少させるための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240033280A1 (https=) |
| EP (1) | EP4221720A4 (https=) |
| JP (1) | JP2023543898A (https=) |
| KR (1) | KR20230079394A (https=) |
| CN (1) | CN116348125A (https=) |
| AU (1) | AU2021353849A1 (https=) |
| BR (1) | BR112023004012A2 (https=) |
| IL (1) | IL300882A (https=) |
| MX (1) | MX2023003855A (https=) |
| WO (1) | WO2022072244A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL277889B2 (en) | 2018-04-12 | 2025-01-01 | Wave Life Sciences Ltd | Oligonucleotide preparations and methods of using them |
| EP3790596A4 (en) | 2018-05-11 | 2022-04-06 | Wave Life Sciences Ltd. | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE |
| AU2023372971A1 (en) * | 2022-11-02 | 2025-05-15 | Ionis Pharmaceuticals, Inc. | Methods for modulating complement factor b expression |
| WO2024194686A2 (en) | 2023-03-17 | 2024-09-26 | Oxitope Pharma B.V. | Anti-phosphocholine antibodies and methods of use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7598227B2 (en) * | 2003-04-16 | 2009-10-06 | Isis Pharmaceuticals Inc. | Modulation of apolipoprotein C-III expression |
| AU2014216137B2 (en) * | 2013-02-14 | 2018-05-10 | Ionis Pharmaceuticals, Inc. | Modulation of Apolipoprotein C-III (ApoCIII) expression in lipoprotein lipase deficient (LPLD) populations |
| JP2018511555A (ja) * | 2015-02-27 | 2018-04-26 | アイオーニス ファーマシューティカルズ， インコーポレーテッドＩｏｎｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． | リポジストロフィー集団におけるアポリポタンパク質Ｃ−ＩＩＩ（ＡｐｏＣＩＩＩ）発現の調節 |
| US20190046555A1 (en) * | 2015-11-06 | 2019-02-14 | Ionis Pharmaceuticals, Inc. | Conjugated antisense compounds for use in therapy |
-
2021
- 2021-09-24 IL IL300882A patent/IL300882A/en unknown
- 2021-09-24 BR BR112023004012A patent/BR112023004012A2/pt unknown
- 2021-09-24 US US18/247,567 patent/US20240033280A1/en active Pending
- 2021-09-24 MX MX2023003855A patent/MX2023003855A/es unknown
- 2021-09-24 EP EP21876250.8A patent/EP4221720A4/en active Pending
- 2021-09-24 CN CN202180066569.6A patent/CN116348125A/zh active Pending
- 2021-09-24 KR KR1020237013301A patent/KR20230079394A/ko active Pending
- 2021-09-24 JP JP2023520059A patent/JP2023543898A/ja active Pending
- 2021-09-24 AU AU2021353849A patent/AU2021353849A1/en active Pending
- 2021-09-24 WO PCT/US2021/052001 patent/WO2022072244A1/en not_active Ceased